actually today is best time/cash all year - 10 % profit in 24 hours . Everyone is whipsawed. These guys gotballs, so I play it . If I get trapped I can afford it. ..but when a stock goes up on nothing .theres gotta be a reason - we know short covering , now the question becomes. ..Have more fun!
trade out ! too tempting take the 10%
Roberts mad that I paid today what he did 5 and half years ago , but kvncmcdd deleted that also ...
INSM is still pure cash value of years ago,but there is more clarity. The cystic fibrosis indication revenue loss in the US might be offset if the Phase3 NTM trial widens the patient population in 2018 With a ruling and approval not due for many months in Europe and the FDA mandated multiyear NTM trial , on the face of it, it appears that in 2015 Insmed will be dead money, but I dont.
I love posts about preclinical IND work. Lets talk pricing! Thanks for the laugh.
trading and tax loss selling season is basically over , until oil stabilizes, the market will continue to fall
YTD + 200% with INSM covered Friday morning ( the trade was quickly erased...lol )
Covered my short this morning (still not sure why there was volume) but Ill take it and the
200% profit I have made trading Insmed YTD.
lol ! girls gotcha down? Cathy has asked me? Are these really adults? .
My posts on Cubist the CF US sales and of course my trades do hold up,even poor zippy got deleted..
YTD + 200% - on the sidelines
Have more fun !
I have never said I didnt think Insmed could not be a winner. I rank the juvenile and stupid Billions! Iplex and other continual nonsense. I said that Insmed is about NTM in the US in a few years. IF the phase3 trial in the US expands the patient population I will be onboard...until that- Insmed remains a trading stock.
YTD+193% and amused.
Imagine how pisdoff INSM shareholders will be to realize that they have no stake in Shire whatsoever. All rights including mfg were given to Shire for a mere 11 M.
Those gullible enough to believe a pharma would spend hundreds of Millions to produce a drug and save Insmed start up costs should not be in biotech.
Have more fun!
Cathy posted the Patient Information Sheet Approved 12/2005 by the FDA and the Iplex packing insert label Reposting of the labeling insert ; just facts = INSM did make the following statement, which can be found in the iPlex package insert: "Hypoglycemia was reported in 11/36 (31%) patients in the study generally rated as mild and asymptomatic. Four hypoglycemic episodes were characterized as symptomatic including two cases that required acute intervention."
by terry_insm •15 hours ago "Watch the stupid responses." ....and they didn't disappoint
Dragging out old IDs and discredited rumors,kvncmcdd and fudblasedp31 showed why after a decade ,they are still holding their beloved 1.40 stock. Insmed may have a good future with Arikayce but Iplex informed investors know is a failed drug with no promise.
A month or so ago I did my what seems my annual Iplex info thread and laughed . No matter how much factual info was presented , the ignorance and the stupid questions appeared and still do. ( witness historians here)
Never did they realize or answer questions on why Iplex was a bust for short stature. biowatchdog( sic- guess who) wasnt even sure there were sales.
What was side effect that stunted sales I asked? - Not one answer..... but it is HYPOGLYCEMIA ! , and is also why there were just a handful of ALS patients. I know a physician who could have, but refused iplex as an option.
I posted what the FDA said regarding ALS ,( no improvement) why Insmed refused to invest in a P2 trial and on and on. Iplex has been a drug failure. There is not one indication that produced results that would be worthy of investment for this company. All rights to the only indication showing promise have been sold.
Watch the stupid responses. These clowns should not be in biotech. They love to makeupblcht and I mean TOTALblcht.
terry_insm •"shorts are adding " to zake1 and my response were quickly deleted , so I just put up my position and laugh all the way to the bank. YTD + 193% and short ....so I can afford the risk.
tom.berry169 • Maybe you're adding, but anybody adding to a short here is ignoring technical analysis at his peril.
terry_insmed • Not bad, and as soon as it touched the 200 I added. We shall see
basis raised, short from $15.17 Good Luck
while screening stocks today , the wunderkind ICPT is now 136 ( but a trade ) - always take profits . The thread on this board is funny to read . ......
and both are missing the point.If you are a chartist , you may be looking at patterns or signals and not minute changes. If you are an investor you either don't care ( and shouldn't if you have valid reasons for choosing Insmed as an investment) or you are evaluating the positioning - dependent on your own personal risk tolerance and time frame..That's what I am doing. Good Luck
ps - No surfing ! its raining in Southern California! and people are melting everywhere!
There is no mystery to Black Fridays trading. The technical sell signal I took again .
terry_insmed • Nov 28, 2014 11:26 AM "kvncmcdd... " See the signal now? Of course not "
Sentiment : short ($14.67) YTD + 193% (+4% yesterday when I cover) Good Luck
INSM Longs are down 23 % YTD and poor traders like kvncmcdd almost 60%. but investors can cut their losses if you have other winners by tax loss selling.
This is the time of the year this tax advantage is usually executed (there is often a "Santa Claus rally" in Dec .) This tax shelter will be putting addition pressure on INSM the next few weeks.
YTD -I am out Up 193% on INSM
Congrats to Seeking alpha- Andy Batts who receives $35 + $0.01/page view This piece of spam from the advertising site "seeking alpha" is planted hype .This is not to say Insmed is not an attractive stock,this is a slanted article that misses many of the points investors should know if developing an investment strategy.(buy buy buy ! ) This seemingly pro Insmed "article" is a short interest spamplant"- betcha.
ps - note about : " See Seeking Alpha's policy on anonymous authors."
YTD + 193% and out - great trading today ...Surfs up!
"What does the FDA think of Iplex for ALS? " Like most Informed Insmed investors I have ignored much of the disinformation regrading the iplex fraud on this board. A few weeks ago theclowns said ALS! Shire manufacture- clearly a fabricated pceofcht.- repost from years ago Thanks to Cathy:
The FDA statement on iplex in 09
" "After careful review and consideration, FDA denied iplex " because the agency was not aware of any data that suggested that Iplex was beneficial in the treatment of ALS.
In addition, FDA was aware of data from controlled trials for a very similar drug (IGF-1 or Myotrophin) that failed to demonstrate benefit, and in some trials suggested a worse outcome "
"the FDA was aware of reports that Iplex was being made available for treatment use in Italy under a court order. FDA contacted its counterpart agency in Italy to request information about that program and to inquire about any data that may have been collected from that experience. FDA learned that more than 100 patients with ALS had received court-ordered treatment in Italy, and the agency received a summary report of the data provided to the Italian government by Insmed in March 2008. FDA reviewed that report,( my comment the infamous "swallowing" blcht) " the data were not interpretable with regard to determining any benefit of Iplex in the treatment of ALS, "
Cathy said a poster (removed by the clowns this weekened ) answered the medical reason the drug was shunned and was close. The compassionate care program (IND) was also a bust.
Get over it kids, iplex is long dead... become investors notblchtartists
Covered, 2014 I posted 9 calls I picked the top ( go short) 4 times and a long with the CF news and even a few day trades.No one knows this better than kvncmcdd,this boards trading fraud who also picked the tops and always bought more !
I've made a ton trading Insmed for a decade and have helped others- INSM has actually been a very easy trading biotech stock
Insmed may finally become an investment and there will be telegraphing signals for sure.
Longs are down 22% in 2014 after a great 2013, but numbers show most are invested here in the 10-11 dollar range... Good Luck